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During passage through the epididymis, sperm interact with
secreted epididymal proteins that promote maturation, including
the acquisition of motility and fertilization competence. Viewed
previously as distinct from sperm maturation, host defence capa-
bilities are now recognized functions of the human epididymis 2
(HE2) family of sperm-binding proteins. We analysed the potent
dose and time-dependent bactericidal activity of recombinant
HE2α, HE2β1 and HE2β2 and found that the full-length proteins
(10 µg/ml or ∼ 1 µM) caused more than a 50 % decrease
in Escherichia coli colony forming units within 15 min. By
contrast, human β-defensin-1, at a similar concentration, required
more than 90 min to exhibit similar antibacterial activity. The
epididymis-specific lipocalin, LCN6, failed to kill bacteria.
Higher concentrations (25–100 µg/ml) of HE2 proteins and a
longer duration of treatment resulted in near total inhibition of
bacterial growth. The C-terminal peptides of HE2α, HEβ1 and
HEβ2 proteins exhibited antibacterial activity similar to their full-
length counterparts, indicating that the antibacterial activity of
HE2 proteins resides in these C-terminal regions. Antibacterial
activities of HE2 proteins and peptides were slightly inhibited by
NaCl concentrations of up to 150 mM, while human β-defensin-
1 activity was nearly eliminated. Reduction and alkylation of
disulphide bonds in HE2 proteins and their C-terminal peptides
abolished their antibacterial activity. Consistent with the ability
to kill bacteria, full-length HE2 proteins and C-terminal peptides
caused rapid dose-dependent permeabilization of outer and
cytoplasmic E. coli membranes. A much longer exposure time
was required for human β-defensin-1-mediated permeabilization
of membranes, suggesting a possible difference in mode of action
compared with the HE2 antibacterial peptides.
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INTRODUCTION
Antimicrobial proteins and peptides are vital components of the
innate immune systems that protect plants and animals against
invading pathogens. In animals these proteins are involved in
a variety of pathophysiological conditions [1–4]. Host defence
proteins of the male reproductive tract have become a subject of
investigation [5], in part because of their potential importance in
sexually transmitted diseases. Antimicrobial proteins reported
in the male tract include the cathelicidins [6], human cationic
antimicrobial protein (hCAP)-18 [7,8], bovine seminalplasmin
[9,10], lactoferrin [11], the protease inhibitors cystatin 3 [12,13],
cystatin 11 [14] and secretory leukocyte protease inhibitor [15,16],
as well as members of the β-defensin family [17–20] and Bin1b
[21]. Of these, hCAP-18 [7], lactoferrin [11] and cystatin 11 [14]
bind the surface of sperm, as do the human epididymis 2 (HE2),
proteins [22,23]. Sperm acquire these proteins during passage
through the epididymis, where they develop mature functions
including forward motility and the ability to fertilize the egg.
The HE2 gene (sperm antigen 11), encoding human homo-
logues of the rat Bin1b [24] and chimpanzee epididymal
protein 2 [25,26], is located on chromosome 8p23 within the
β-defensin gene cluster. The HE2 gene produces a large family of
alternatively spliced transcripts [23] derived from at least 8 exons
[27]. The exons are variously assembled to encode a series of
Abbreviations used: HE2, human epididymis 2; hCAP, human cationic antimicrobial protein; LCN, lipocalin; CFU, colony forming units; BME,
β-mercaptoethanol; NPN, N-phenyl-1-naphthylamine; diSC3-5, 3,5-dipropylthiadicarbocyanine iodide.
1 To whom correspondence should be addressed (e-mail shh@med.unc.edu).
isoforms containing at least 8 different C-terminal peptides. The
three isoforms, i.e. HE2α, HE2β1, and HE2β2 contain identical
signal peptides and proregions joined to different C-terminal
peptides (Figure 1). The peptides conserve characteristic basic
and hydrophobic amino acids and stabilizing disulphide bonds
similar to those of the β-defensin family [28]. Evidence suggests
that they are cleaved from the proregion by a furin-like proprotein
convertase [29]. β-Defensins are similarly synthesized as 60–
90 amino acid precursors, which are digested by an endogenous
protease to release the active peptides.
Defensins exhibit broad-spectrum antimicrobial activity against
viruses [30,31], fungi, Gram-positive bacteria [32] and Gram-
negative bacteria [33]. Gram-negative bacterial cytoplasm is
enclosed within two membranes separated by a periplasmic space.
Negatively charged phospholipids and lipopolysaccharides of
bacterial outer membranes bind the positively charged defensins,
whereas there is no similar charge interaction with the plasma
membranes of animal cells, which are composed primarily
of neutral lipids [34]. Defensin-induced permeabilization of
bacterial membranes is associated with the cessation of DNA,
RNA and protein synthesis [35] and appears to be the lethal event
resulting in bacterial death [35].
The existence of the HE2 C-terminal peptides in human
epididymal epithelium, fluid and ejaculate was recently demon-
strated [29]. Independent prediction of their existence is provided
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Figure 1 Amino acid sequences of human β-defensin-1, human β-defensin-2 and HE2 isoforms
Amino acid sequences shown in bold correspond to the C-terminal peptides used in the antibacterial assays in this study. The cysteines are underlined. The underlined amino acid sequence in
HE2β1 was used for 3-dimensional structural analysis.
by the cDNAs for the B isoform (accession number AF466346)
and the E isoform (accession number AF466348). These encode
the C-terminal peptides of HE2α and HE2β1, respectively,
bearing only two additional N-terminal amino acid residues
instead of the 46 amino acid proregion.
HE2 proteins and peptides are cationic with pIs ranging from
7–12 and, thus, may exhibit antimicrobial properties similar to
β-defensins, and other cationic antimicrobial proteins and pep-
tides. Indeed, antimicrobial activity of human seminal-plasma-
cationic extracts was reported [20]. The antibacterial activities
of synthetic HE2α and HE2β1 peptides have been reported
recently [29], however, the mechanisms involved are not well
understood. Furthermore, little is known about the mechanism of
antibacterial action of the earlier reported antimicrobial proteins
in the reproductive tissues [5]. Here we analyse the antibacterial
activities of HE2α, HE2β1, and HE2β2, mature proteins
and their C-terminal peptides. Structural similarities between
β-defensins and HE2 proteins prompted us to determine whether
permeabilization of outer and inner E. coli membranes is an event
in HE2-mediated bacterial cell death. Our results demonstrate
that HE2 proteins and peptides exhibit structure-dependent
antibacterial activity, which is salt-tolerant and involves a rapid
outer and inner membrane permeabilization.
EXPERIMENTAL PROCEDURES
Three-dimensional structural analysis of HE2β1
The bioinbgu server (http://www.cs.bgu.ac.il/∼bioinbgu/) [36],
was used to thread the sequence of HE2β1 C-terminal peptide
from Gly-52 to Asn-91 on to the structure of human β-defensin-
2, 1FD3.pdb in the Protein Data Bank [37]. A model of HE2β1
peptide was built using the Modeler module of the Insight II
molecular modelling system from Accelrys Inc. (San Diego, CA,
U.S.A. and http:// www.accelrys.com). The figure was created
using SPOCK [38] in the Structural BioInformatics Core Facility
(University of North Carolina at Chapel Hill, NC, U.S.A.) under
the direction of Dr Brenda Temple.
Recombinant protein production and peptide synthesis
Recombinant proteins were prepared as described previously
[23]. In brief, E. coli strain M15 (pREP4) was transformed with
pQE30 vector (Qiagen, Valencia, CA, U.S.A.) containing HE2α,
HE2β1, HE2β2 or lipocalin (LCN)6 cDNA according to the
Qiagen protocol. Fusion-protein expression was induced with
1 mM isopropyl β-D-thiogalactoside for 2 h at 37 ◦C. Bacterial
lysate, incubated with Ni2+-nitrilotriacetate-agarose (Qiagen) was
transferred to acolumn, washed and eluted according to the
manufacturer’s recommendations. Fractions were analysed on
10–20% gradient Tris/Tricine gels (InVitrogen, Carlsbad, CA,
U.S.A.) and stained with Coomassie Blue G250. Fractions
containing purified protein were pooled and dialysed against
10 mM sodium phosphate buffer (pH 7.4) to remove urea. The His
tag was removed using the Tagzyme system (Qiagen) according
to the manufacturer’s protocol. Tagzyme removed the entire tag
leaving the HE2 proteins intact. The recombinant HE2 proteins
and HE2β1 peptide contained the following additional amino
acid residues at their N-termini (MRGSHHHHHHGS), due to the
construction of vector H2N-MRGSHHHHHHGS-COOH.
HE2α and HE2β2 C-terminal peptides without the His tag
were synthesized at the Peptide Synthesis Facility (University of
North Carolina, Chapel Hill, NC, U.S.A.) by standard fluoren-
9-ylmethoxycarbonyl (‘Fmoc’) solid-phase procedures using a
Rainin symphony multiple peptide synthesizer (Rainin Instru-
ment, Woburn, MA, U.S.A.). The purified peptides eluted as single
peaks upon reverse phase HPLC and were further demonstrated
to have their corresponding molecular mass by matrix-assisted
laser-desorption ionization–time-of-flight (‘MALDI-TOF’) mass
spectrometry. HE2β1 C-terminal peptide was expressed in
E. coli and purified as described for the full-length proteins. The
control peptides c-JUN (DPYRGLKGPGARGPGPEGGC) and
CREB (KILNDLSSDAPGVPA) were synthesized at the Peptide
Synthesis Facility.
Reduction and alkylation
HE2 proteins and peptides were reduced and alkylated
according to the protocol described at Massachusetts Institute
of Technology Center for Cancer Research, Howard Hughes
Medical Institute (MITCCR-HHMI) biopolymers laboratory web
site (http://web.mit.edu/biopolymers/www/protein−sequencing.
html). Briefly, the protein or peptide (10 µg) in 0.3 M Tris/HCl
buffer (pH 8.0) containing 8 M urea as a denaturant was treated
with β-mercaptoethanol (BME; Sigma, St. Louis, MO, U.S.A.)
under nitrogen for 4 h at 37 ◦C to reduce the disulphide bonds.
The reduced protein was alkylated immediately by adding
iodoacetamide (Sigma) in a 20% molar excess over the total
number of thiols, and incubated for 1 h at 37 ◦C in the dark,
under nitrogen. The reaction was terminated by freezing the
samples immediately in a −80 ◦C freezer, followed by dialysis
against 10 mM sodium phosphate buffer (pH 7.4) to remove
excess BME and iodoacetamide. A control reaction, containing
sodium phosphate buffer without protein, was treated similarly
to determine whether residual BME and iodoacetamide affected
bacterial growth in the assays.
c© 2003 Biochemical Society
Antibacterial activities of human epididymis 2 proteins and peptides 475
Antibacterial assays
A colony forming units (CFU) assay was employed to test
the antibacterial activity as described previously [40]. Briefly,
overnight cultures of E. coli XL-1 blue (Stratagene, La Jolla,
CA, U.S.A.) were allowed to grow to mid-log phase (A600 = 0.4–
0.5) and diluted with 10 mM sodium phosphate buffer (pH 7.4).
Approximately 2 × 106 CFU/ml of bacteria were incubated at
37 ◦C with 10–100 µg/ml of the proteins or peptides, and aliquots
of the assay mixture were taken at 5, 10, 15 and 30 min after
the start of incubation. After incubation, the assay mixtures were
serially diluted with 10 mM sodium phosphate buffer (pH 7.4)
and 100 µl of each was spread on a Luria–Bertani agar plate and
incubated at 37 ◦C overnight to allow full colony development.
The resulting colonies were hand counted. Human β-defensin-
1 (Peptide Institute Inc., Osaka, Japan) was used as a positive
control. BSA (Sigma) was used as a negative control. To test
the effect of high salt on antibacterial activity, E. coli were
incubated for 2 h with the protein or peptide in 10 mM sodium
phosphate buffer (pH 7.4) containing varying concentrations of
NaCl ranging from 25 to 300 mM. Following incubation, the
assay mixtures were diluted with 10 mM sodium phosphate buffer
(pH 7.4), without added salt, and spread on Luria–Bertani agar
plates as described above. Antibacterial activity expressed as per-
centage survival was calculated using the following formula:%
survival = (number of colonies surviving after treatment with
the antibacterial peptide/number of colonies surviving without the
antibacterial peptide) × 100.
Outer-membrane-permeability assay
The ability of epididymal proteins and their peptides to per-
meabilize the outer membrane of E. coli was assessed by the
N-phenyl-1-naphthylamine (NPN; Molecular Probes, Eugene,
OR, U.S.A.) assay of Loh et al. [41]. An overnight culture of
E. coli was grown to mid-log phase, washed twice with 5 mM
Hepes buffer (pH 7.4) containing 5 mM glucose, and resuspended
in the same buffer containing 10 µM NPN up to an A600 of 0.25.
To a 60 µl aliquot of this suspension, varying concentrations of
the protein or peptide were added. Fluorescence was monitored
using an Aminco SLM 8100 fluorescence spectrophotometer
(SLM Instruments Inc., Urbana, IL, U.S.A.) with the exci-
tation monochromator set at 350 nm and the emission set at
420 nm.
Inner-membrane-permeability assay
Permeabilization of the cytoplasmic membrane was determined
using the cyanine dye 3,5-dipropylthiadicarbocyanine iodide
(diSC3-5; Molecular Probes, Eugene, OR, U.S.A.) by the method
of Wu et al. [42]. Mid-log phase E. coli were washed twice
with 5 mM Hepes buffer (pH 7.4) containing 5 mM glucose,
and resuspended in the same buffer up to an A600 of 0.05.
The cell suspension was incubated with 0.4 µM diSC3-5 until
the uptake was maximal, as indicated by a stable reduction in
fluorescence. To this suspension varying concentrations of the
protein or peptide were added and the fluorescence was monitored
in an Aminco SLM 8100 fluorescence spectrophotometer with
the excitation monochromator set at 622 nm and the emission at
670 nm.
Haemolysis assay
Haemolytic activity of epididymal proteins and their peptides
was determined as described previously [43]. Erythrocytes from
heparinized rat blood were washed three times with 0.9%
saline and resuspended to a concentration of 5% in saline.
Erythrocytes were treated with different concentrations of the
proteins or peptides (10 µg/ml to 100 µg/ml) in a 96-well plate
and incubated at 37 ◦C for 1 h. The plate was centrifuged at 1000 g
for 10 min and supernatants were transferred to a fresh plate.
Absorbance (at 560 nm) of saline and 1% Triton X-100-treated
erythrocytes served as 0% and 100% haemolysis controls,
respectively.
RESULTS
Three-dimensional structural analysis of HE2β1
The predicted three-dimensional structure of defensin-like
HE2β1 peptide having the 6-cysteine array (Figure 2) was
modelled, based on the crystal structure of human β-defensin-
2 [44]. HE2β1 C-terminal peptide is predicted to form a short
N-terminal amphipathic α-helix and a three-stranded twisted
β-sheet, stabilized by three disulphide bridges. Like defensins,
Figure 2 HE2β1 peptide model
(A) Ribbon model showing the architecture of α-helix and 3β-strands (B) Space-filled model.
Basic amino acids are blue and hydrophobic amino acids are green. N indicates the N-terminal
Gly-52 and C indicates the C-terminal Asn-91. The 3 disulphide bonds are indicated in yellow.
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Figure 3 Kinetics of E. coli-killing by HE2 proteins
E. coli were incubated for 5–30 min with 10 µg/ml (), 25 µg/ml (), 50 µg/ml (), and 100 µg/ml () protein. (A) HE2α, (B) HE2β1 and (C) HE2β2. Insets in panels A, B and C show the
antibacterial activity of HE2 proteins with () and without () His-tag incubated with E. coli for 15 min. (D) Antibacterial activity of LCN6 after 2 h incubation.
HE2β1 peptide tertiary structure presents regional concentrations
of basic and hydrophobic amino acids that may be involved in
mediating bacterial killing (reviewed in [45]).
Antibacterial activity
To analyse HE2α, HE2β1, and HE2β2 antibacterial activity, a
10-fold concentration range of each protein was incubated with
E. coli for 5–30 min (Figures 3A–3C). Approx. 10% of bacteria
survived after incubation with 25 µg/ml (2.8 µM) HE2α for
10 minutes. Similar results were seen after incubation with
10 µg/ml (1.07 µM) HE2β2. In the case of HE2β1, 50 µg/ml
(4.1 µM) for 15 minutes was required to reduce bacterial survival
to 10%. The inset (Figures 3A–3C) shows the antibacterial
activity of HE2 proteins with and without the His tag. The
antibacterial potencies of the His tag removed HE2 proteins
were similar to those of their His-tagged counterparts. The
control proteins, recombinant LCN6 (Figure 3D) and BSA (results
not shown) showed no detectable antibacterial activity when
incubated for 2 h at concentrations up to 100 µg/ml.
Similar to the full-length proteins, the HE2α, HE2β1, and
HE2β2 C-terminal peptides exhibited potent dose and time-
dependent antibacterial activity against E. coli (Figures 4A–4C).
A 90% reduction in CFU was observed after incubation with
50 µg/ml (14.2 µM) HE2α peptide for 10 min, whereas the
HE2β1 and HE2β2 peptides were more effective. HE2β1 peptide
caused a 90% reduction in CFU after incubation for 10 min at
25 µg/ml (2.65 µM) and the HE2β2 peptide reduced survival to
zero after 10 minutes incubation at all concentrations tested. Thus,
the potencies of HE2β1 and HE2β2 peptides were similar to the
full-length proteins, consistent with the prediction that the activity
resides in the C-terminal peptides. The lower activity of HE2α
C-terminal peptide compared with the full-length protein was
unexpected and may indicate a stabilizing or protective effect of
the pro-region on the HE2α peptide. Removal of the His tag from
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Figure 4 Kinetics of E. coli-killing by HE2 C-terminal peptides and human β-defensin-1
E. coli were incubated for 5–30 min with 10 µg/ml (), 25 µg/ml (), 50 µg/ml (), and 100 µg/ml () peptide, (A) HE2α peptide, (B) HE2β1 peptide and (C) HE2β2 peptide. The inset in
panel B shows the antibacterial activity of HE2β1 peptide with (), and without () His-tag incubated with E. coli for 15 min. (D) Antibacterial activity of human β-defensin-1. E. coli were incubated
with human β-defensin-1 for 1–3 h with 0 µg/ml (), 10 µg/ml (), 25 µg/ml (), 50 µg/ml (), and 100 µg/ml ().
the recombinant HE2β1 peptide slightly reduced its antibacterial
activity (Figure 4B, inset). Human β-defensin-1 antibacterial ac-
tivity was much slower acting than the HE2 peptides in
these assays. After 90 min exposure to human β-defensin-1
(100 µg/ml), 20% of the bacteria survived (Figure 4D).
Not until after 180 min exposure were CFU reduced below the
limits of detection (results not shown). Control synthetic peptides
of transcription factors CREB and c-JUN did not affect bacterial
survival and growth, even after 2 h exposure to 100 µg/ml (results
not shown).
The conserved arrangement of the six cysteines in β-defensins
supports the concept that specific disulphide bridges are required
for full antibacterial function. Recent studies showed that
antibacterial activity was preserved when at least one disulphide
bond was present in each active peptide [46]. To determine
whether HE2 disulphide bonds are essential for antibacterial
activity, disulphide bonds in the three proteins and C-terminal
peptides were reduced and alkylated. These denatured full-
length proteins and peptides completely failed to kill E. coli
even when incubated for 2 h at a concentration of 100 µg/ml
(Figure 5) indicating the requirement for disulphide-bond-
constrained tertiary structure for the antibacterial activity.
β-Defensins are reported to lose antibacterial activity in high-
salt conditions possibly due to interference with electrostatic
interactions with bacterial surfaces [1,40,47,48]. Whether HE2
peptides were similarly affected by ambient salt concentrations
was determined by incubating full-length proteins and C-terminal
peptides for 2 h with E. coli in 0–300 mM NaCl. The presence
of NaCl alone, without peptides, increased bacterial growth
substantially. In the absence of NaCl, 0–3% of bacteria survived
in the presence of HE2 proteins (Figure 6A) or peptides
(Figure 6B). In the presence of increasing salt concentrations,
bacterial survival increased in the presence of HE2 proteins and
peptides. However, substantial antibacterial activity was retained
in up to 150 mM NaCl. In 150 mM NaCl, HE2β1 activity was
the most salt-sensitive of the three HE2 isoforms with 25%
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Figure 5 Effect of disulphide bond reduction and alkylation on the
antibacterial activity of HE2 proteins and peptides
E. coli were incubated for 2 h with 100 µg/ml disulphide-bond reduced protein or peptide.
NaPO4 indicates E. coli incubated with only 10 mM sodium phosphate buffer (pH 7.4) without
any added protein or peptide. Control indicates sodium phosphate buffer without protein was
given the same treatment as alkylating proteins and dialysed to determine whether residual BME
and iodoacetamide affected bacterial growth in the assays.
bacterial survival increasing to 30% survival in 300 mM salt.
HE2α maintained 10% bacterial survival at 150 mM NaCl and
20% survival at 300 mM NaCl. HE2β2 was the most salt-tolerant,
permitting less than 4% bacterial survival in 150 mM NaCl and
10% survival in 300 mM NaCl. Similar results were obtained
with the C-terminal peptides except that there was greater loss
of activity at 300 mM NaCl. Human β-defensin-1 antibacterial
activity was more salt-sensitive than that of HE2 peptides, losing
much of its activity at NaCl concentrations as low as 50 mM.
When compared to HE2 C-terminal peptides, the full-length
HE2 proteins retained somewhat greater antibacterial activity at
300 mM salt concentration.
Outer-membrane permeabilization
The ability of HE2 proteins and their C-terminal peptides to
permeabilize the outer membrane of E. coli was tested using
NPN dye which fluoresces weakly in an aqueous environment,
but strongly in the hydrophobic interior of cell membranes. Upon
destabilization of the outer bacterial membrane by antimicrobial
peptides, the dye enters the damaged membrane where it emits
stronger fluorescence [49]. Incubation of bacteria with HE2α,
HE2β1, and HE2β2 proteins as well as with HE2α and HEβ2
C-terminal peptides resulted in a rapid dose-dependent increase
in fluorescence within 3 min (Figures 7(A) and 7B). However,
HE2β1 peptide resulted in a weak increase in fluorescence
(Figure 7B). In contrast, the control LCN6 caused no change in the
fluorescence. The right-hand panel in Figure 7(A) shows the time
course of outer membrane permeabilization. HE2 proteins without
the His tag had similar outer-membrane-permeabilizing activities
when compared to their His-tagged counterparts. Exposure to
the reduced and alkylated HE2 proteins and peptides resulted in
no change in fluorescence, indicating that without the structural
integrity conferred by disulphide bonds, the HE2 isoforms were
unable to disrupt the bacterial outer membranes (Figure 7C).
Figure 6 Effect of NaCl on the antibacterial activity of HE2α, β1 and β2
proteins and peptides
E. coli were incubated for 2 h with 25 µg/ml protein or peptide in 10 mM sodium phosphate
buffer (pH 7.4) containing the indicated concentrations of NaCl. (A) Effect of NaCl on the
antibacterial activity of HE2α, β1 and β2 proteins. NaCl alone (), HE2α (), HE2β1 ()
and HE2β2 (). (B) Effect of NaCl on the antibacterial activity of HE2α, β1 and β2 peptides.
NaCl alone (), HE2α peptide (), HE2β1 peptide (), HE2β2 peptide (), and human
β-defensin-1 ().
Inner-membrane permeabilization
The cytoplasmic inner-membrane-permeabilization capacity of
the HE2 family of epididymal proteins and peptides was
investigated further using diSC3-5 dye that distributes itself
between the cell interior and the medium according to the
membrane potential. The dye accumulates in self-quenching
aggregates inside the cell, allowing uptake to be measured
as decreasing fluorescence. In our experiments, fluorescence
declined to 20% of original levels in 10–15 min and remained
stable until HE2 proteins or peptides were added (results not
shown). Addition of peptides resulted in the release of dye
and a rapid increase in fluorescence (Figures 8A and 8B).
Increased fluorescence was detectable within 2 min and the dye
was maximally released within 5 min after adding HE2 protein
or peptide (Figure 8A, right-hand panel). His tag removal from
HE2 proteins did not affect their inner-membrane-permeabilizing
abilities. Reduced and alkylated HE2 proteins and peptides failed
to damage the inner membrane (Figure 8C).
Human β-defensin-1 also caused both outer- and inner-
membrane permeabilization. However it required longer incuba-
tion time periods with E. coli than did the HE2 proteins and
peptides. As seen in Figure 9(A) and 9(B), HE2β2 peptide caused
dose-dependent disruption of the outer and inner membranes
within 1–5 min, whereas human β-defensin-1 required 60–
150 min to achieve the same effects.
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Figure 7 Outer-membrane permeabilization mediated by HE2 proteins and their C-terminal peptides as assessed by NPN uptake
(A) Outer-membrane permeabilization by HE2 proteins. Left-hand panel: concentration-dependent E. coli outer-membrane permeabilization mediated by HE2 proteins and LCN6 at 3 min. HE2α (),
HE2β1 (), HE2β2 (), LCN6 (). Right-hand panel: time course of outer-membrane permeabilization at a concentration of 50 µg/ml HE2 proteins with (solid line) and without (dashed line) His tag.
(B) Concentration dependence of outer-membrane permeabilization mediated by HE2 C-terminal peptides at 3 min. HE2α peptide (), HE2β1 peptide (), HE2β2 peptide (). (C) Outer-membrane
permeabilization by disulphide-bond reduced and alkylated HE2 proteins and peptides. HE2α (), HE2β1 (), HE2β2 (), HE2α peptide (), HE2β1 peptide (), HE2β2 peptide (),
and control (, indicating that sodium phosphate buffer without protein was treated in the same manner as for alkylating the proteins, and dialysed to determine whether residual BME and
iodoacetamide affected the release of dye in the assays).
Haemolysis
An erythrocyte assay was used to test the sensitivity of eukaryotic
membranes to attack by HE2α, HE2β1, and HE2β2. No
haemolysis was detected after 1 h exposure of rat erythrocytes to
HE2 proteins or peptides even at a concentration of 100 µg/ml
(results not shown). This result suggests that eukaryotic cell
membranes are not as sensitive as E. coli membranes to disruption
mediated by HE2 proteins and peptides. Like the erythrocytes, the
neutral membranes of the epithelial cells lining the epididymis and
the sperm are probably resistant to the destructive effects of HE2
proteins that are secreted into the epididymis lumen.
DISCUSSION
Sperm released from the seminiferous tubules of the testis acquire
fertilizing ability as they pass through the epididymis. Several
epididymis-specific proteins belonging to different families have
been identified in recent years, however, the functions of most of
these proteins are not yet known. Earlier work in our laboratory
[14,23,50,51] and others [7] identified human epididymal proteins
including the splice variant HE2 gene products (HE2α, HE2β1
and HE2β2) and demonstrated their presence on ejaculated
sperm. These proteins are expressed in the efferent ducts and
initial segment of epididymis [23] and are available to interact
with sperm as they leave the testis. Acquisition of fertilizing
ability in the epididymis may be dependent on sperm-bound
HE2 proteins. The structural features of HE2 proteins that cause
disruption of bacterial membranes may alter the sperm plasma
membrane in a manner that promotes sperm maturation rather
than membrane destruction. The antibacterial activity displayed
by HE2 proteins and peptides may be attributed to their cationic
nature and similarity to β-defensins. Whether HE2 proteins retain
their antibacterial capacity while bound to sperm and whether
the C-terminal peptide is released from sperm in the male or
female tracts to interact with bacterial membranes remain to be
determined.
In the presence of HE2 proteins, the outer E. coli membrane
was disrupted within 30 s and the inner membrane within 2 min.
Bacterial cell death was effected after a 5 min exposure to HE2
proteins. HE2 proteins killed bacteria after a shorter exposure
than human β-defensin-1, which required 1 h to disrupt the
outer membrane and 2 h for disruption of the inner membrane.
Membrane disruption was shown previously for indolicidin
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Figure 8 Inner-membrane permeabilization mediated by HE2 proteins and peptides as assessed by diSC3-5 assay
The specified concentration of the native or denatured protein or peptide was added to E. coli and florescence was monitored. (A) Inner-membrane permeabilization by HE2 proteins and LCN6.
Left-hand panel: concentration dependent E. coli inner-membrane permeabilization by HE2 proteins at 10 min. HE2α (), HE2β1 (), HE2β2 (), and LCN6 (). Right-hand panel: time
dependence of inner-membrane permeabilization by 50 µg/ml HE2 proteins with (solid line) and without (dashed line) His tag. (B) Concentration dependence of inner-membrane permeabilization
mediated by HE2 C-terminal peptides. HE2α peptide (), HE2β1 peptide (), HE2β2 peptide (). (C) Inner-membrane permeabilization by disulphide-bond reduced and alkylated HE2 proteins
and peptides. HE2α (), HE2β1 (), HE2β2 (), HE2α peptide (), HE2β1 peptide (), HE2β2 peptide (), and control (, indicates sodium phosphate buffer without protein was treated in
the same manner as for alkylating the proteins and dialysed to determine whether residual BME and iodoacetamide affected the release of dye in the assays).
[52,53], bactenectin [54], plant defensins [55] and peptides
belonging to different classes [56]. Structural changes in the
E. coli and Staphylococcus aureus outer membranes were ob-
served when exposed to high concentrations of α-defensins
[57,35]. The loss of microbial viability brought about by anti-
microbial peptides has been attributed to one or more of the
following events: (1) formation of pores that cause cellular
contents to leak [58], (2) interaction with critical factors inside the
cell [59], (3) depolarization of the bacterial membrane [60],
(4) changes in the distribution of membrane components [61], and
(5) activation of cell-wall-degrading enzymes such as hydrolases
[62]. Whether the loss of bacterial viability is due solely
to membrane permeabilization, or whether HE2 proteins also
interact with specific targets inside the bacteria is yet to be
determined.
HE2 epididymal proteins contain varying numbers of cysteine
residues, which are assumed to form intramolecular disulphide
bonds. Membrane disruption and bacterial-killing activities of
these proteins and peptides were abolished by reduction and
alkylation of the disulphide bonds indicating the dependence
of these activities on tertiary structure. Similarly, disulphide
bond reduction cancelled the channel-forming activities of insect
defensins [63] and protegrins [64] and the antibacterial activities
of several other proteins [65–68]. It has been suggested that the
disulphide bridges position positively charged and hydrophobic
amino acids in clusters, effective in binding bacteria [69].
Antibacterial activities of HE2 proteins were clearly less
inhibited by NaCl than was the activity of human β-defensin-
1. Salt tolerance was demonstrated for the antimicrobial activity
of several cathelicidin-derived peptides [6], and other peptides
[70–73], whereas β-defensins [1,47,48] and horse cathelicidin
peptides were salt sensitive [74]. The greater salt tolerance
of HE2 proteins compared with human β-defensin-1 suggests
major differences in electrostatic interactions and perturbations
that facilitate membrane disruption. Whether differences in the
arrangement of basic and other amino acids lead to greater
stability of HE2–bacterial interactions remains to be investigated.
However, recent studies suggest that loss of peptide antimicrobial
activity in higher salt concentrations may be related both to the
degree of positive charge of the peptide and to the α-helical
content [40]. In this regard, the most potent peptide in this study,
HE2β2 was the most salt-tolerant and is predicted [36] to contain
a greater content of α-helical structure than human β-defensin-1,
HE2α or β1 peptides.
Antibacterial peptides that lyse bacterial membranes may also
be toxic to eukaryotic cells [43], in which case they would be
unsuitable as systemic drugs. However, in this study, the lack of
haemolytic activity at the highest concentration of peptides used in
c© 2003 Biochemical Society
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Figure 9 HE2β2 peptide mediates more rapid outer- and inner-membrane
permeabilization than human β-defensin-1
(A) Outer-membrane permeabilization mediated by HE2β2 peptide and human β-defensin-1.
(B) Inner-membrane permeabilization mediated by HE2β2 peptide and human β-defensin-1.
antibacterial assays indicated that the red-blood-cell membranes
are not adversely affected. Further studies are required to know
whether eukaryotic membranes are also resistant.
The mechanism of bacterial killing by HE2 peptides appears to
begin with interaction with the outer bacterial membrane leading
to outer and inner membrane disruption and cell death. Further
experiments are needed to address whether interactions of HE2
proteins with specific membrane or intracellular factors contribute
to bacterial destruction as reported for other antimicrobial proteins
[59].
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